NICE and new: appraising innovation

BMJ. 2010 Jan 5:340:b5493. doi: 10.1136/bmj.b5493.
No abstract available

MeSH terms

  • Cost-Benefit Analysis
  • Diffusion of Innovation*
  • Drug Evaluation
  • Financing, Organized
  • Humans
  • Quality-Adjusted Life Years
  • State Medicine / economics
  • Technology Assessment, Biomedical / economics
  • Technology Assessment, Biomedical / organization & administration*
  • Technology, Pharmaceutical / economics
  • Technology, Pharmaceutical / organization & administration*
  • United Kingdom